Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain

NCT01463397 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01463397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01463397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2013
Enrollment
191 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain